Company / Return on Assets (ROA)
Kiniksa Pharmaceuticals International, plc Return on Assets (ROA) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
7.7%
FY2025
5-year range
-69.5% / 39.9%
FY2021-FY2025
Trend
+203.9%
vs FY2024
Sector context
#33 of 213
Health Care
What the data says
Return on Assets (ROA) changed +204% YoY in FY2025, a notable deviation from the 8-year average annual change of -19%.
Based on SEC 10-K filings.
7.7% in FY2025 with a 5-year CAGR of +53.9%. Top quartile in the Health Care sector.
Improved from 2.7% to 7.7% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -32.2pp
- 5-Year Change
- +53.9pp
- 10-Year Change
- -
Sector benchmark
Top 15% in Health CareTop 15% of 213This company 7.7% Sector average -24.2%
▼
+132.0% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 203.9% year-over-year.
- Currently 31.9pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2022.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 7.7% | +203.9% |
| FY2024 | -7.4% | -377.6% |
| FY2023 | 2.7% | -93.3% |
| FY2022 | 39.9% | +157.4% |
| FY2021 | -69.5% | -50.6% |
| FY2020 | -46.2% | +27.4% |
| FY2019 | -63.6% | -98.3% |
| FY2018 | -32.1% | +76.5% |
| FY2017 | -136.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026